Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First human implant for 4F left-heart lead:

This article was originally published in Clinica

Executive Summary

A US electrophysiologist has performed the first human implant of Medtronic's over-the-wire (OTW) steroid-eluting left-heart lead for delivering cardiac resynchronisation therapy in patients with heart failure. The Attain OTW lead (model 4193) has a diameter of only 4 French and is designed to facilitate placement in small and tortuous cardiac veins. Its steroid-eluting capability is designed to stabilise electrical performance. The device is being investigated as part of the Minneapolis, Minnesota company's InSync III study.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069614

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel